Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
(PubMed) Villegas-Salas E, Ponce de Leon R, Juarez-Perez MA, Grubb GS
Phase 3 clinical trials testing GLP-1 RAs for weight management have demonstrated mean weight reduction of 8% to 15%, with 63% to 86% of patients achieving a 5% or greater reduction in body weight, and 33% to 69% achieving a 10% or greater reduction after 13 to 17 months of use
Since all participants already had evidence of liver damage, the trial measured whether participants saw improvements during the trial
The peptide improves hydration, increases elasticity, repairs barrier proteins, and corrects mottled hyperpigmentation
US$ 29.87
US$ 22.57
US$ 20.06
US$ 28.08
US$ 26.15
US$ 23.61
US$ 23.21
US$ 24.61
